LynneV.AbruzzoMD

Medical Genetics • Augusta, GA

Clinical Cytogenetics

Professor, Pathology, Ohio State University College of Medicine

Join to view full profile

Dr. Abruzzo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abruzzo's full profile

Already have an account?

Office
1120 15th St
Augusta, GA 30912
Phone+1 706-721-8623

Fax+1 706-721-1459

Education & Training

University of MichiganResidency, Pathology-Anatomic and Clinical, 1986 - 1990
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1986

Certifications & Licensure

GA State Medical License 2022 - 2025
OH State Medical License 2013 - 2025
SC State Medical License 2024 - 2025
DC State Medical License 1994 - 2014
MD State Medical License 1990 - 2014
TX State Medical License 2000 - 2014
American Board of Pathology Anatomic Pathology & Clinical Pathology
American Board of Pathology Hematology
American Board of Medical Genetics and Genomics Clinical Cytogenetics and Genomics
American Board of Medical Genetics and Genomics Laboratory Genetics and Genomics

Publications & Presentations

PubMed

51 citations
MYC protein expression is an important prognostic factor in acute myeloid leukemia
Maro Ohanian, Uri Rozovski, Rashmi Kanagal-Shamanna, Lynne V. Abruzzo, Sanam Loghavi
Leukemia & Lymphoma. 2019-01-02
165 citations
MicroRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival
Simona Rossi, Masayoshi Shimizu, Elisa Barbarotto, Milena S. Nicoloso, Federica Dimitri
Blood. 2010-08-12
280 citations
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP...
Zijun Y. Xu-Monette, Lin Wu, Carlo Visco, Yu Chuan Tai, Alexander Tzankov
Blood. 2012-11-08

Journal Articles

Trisomy 12 Chronic Lymphocytic Leukemia Expresses a Unique Set of Activated and Targetable Pathways
Michael J Keating, Lynne V Abruzzo, Haematologica

Lectures

Mutations in the Ras Pathway in Pre-Treatment Chronic Lymphocytic Leukemia Are Associated with VH1-69: Linking B-Cell Receptor Stereotypy to Downstream Signaling Events
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

FCR Still an Option in IGHV-Unmutated CLL?October 8th, 2019
Deletion 20q in CLL May Represent Disease ProgressionMay 28th, 2015

Grant Support

Validation Of RNA And DNA Biomarkers Of Prognosis In Chronic Lymphocytic LeukemiaNational Cancer Institute2006–2008